Skip to content
AnalystLens

UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2012

Filing Date
Filed February 7, 2013
Period End
December 31, 2012
Security
UNH
One revenue dollarkept$0.05
In the record · 2016–202610-K1110-Q328-K173

UNH filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 173 current reports (8-K) between 2016 and 2026.

  1. FY2018 annual report10-K · Feb ’19Feb ’19
  2. Leadership change8-K · Feb ’22Feb ’22
  3. Leadership change8-K · Nov ’25Nov ’25

Summary

Summary of the 10-K filed February 7, 2013. Cited figures are marked; the original filing is the authoritative source.

UnitedHealth Group Inc. (UNH) demonstrated robust revenue growth in 2012, an increase of 9% to $110.6 billiona, driven by strong performance in both its UnitedHealthcare and Optum platforms.

The company reported net earnings of $5.5 billionb, a 7% increase year-over-year, with diluted earnings per share rising 12% to $5.28. This growth was fueled by expanded medical enrollment, particularly in Medicare & Retirement and Community & State segments, and strategic acquisitions, notably the significant purchase of Amil in Brazil. The company's diversified business model, encompassing health benefits (UnitedHealthcare) and health services (Optum), positions it to navigate the evolving healthcare landscape.

Despite challenges such as increased medical costs driven by hospital price inflation and utilization trends, UnitedHealth Group managed its medical care ratio effectively, keeping it stable. The company also actively returned capital to shareholders through share repurchases and increased dividends, signaling confidence in its financial stability and future prospects. The report also details the company's ongoing efforts to adapt to the complexities of the Health Reform Legislation, which is expected to shape the future of the healthcare industry.

Key Highlights

  1. Consolidated revenues increased by 9% to $110.6 billion in 2012, driven by growth across both UnitedHealthcare and Optum segments.
  2. Net earnings rose by 7% to $5.5 billion, with diluted earnings per share increasing by 12% to $5.28.
  3. UnitedHealthcare experienced significant medical enrollment growth, adding 6.4 million people, largely due to the acquisition of Amil in Brazil.
  4. The company effectively managed medical costs, maintaining a medical care ratio of 80.4%, with favorable reserve development contributing to profitability.
  5. Optum segments showed strong performance, with OptumHealth revenues up 22% and OptumInsight revenues up 8%, demonstrating growth in health services.
  6. UnitedHealth Group returned significant capital to shareholders, repurchasing 57 million shares for $3.1 billion and increasing its dividend by 31% year-over-year.
  7. The company is actively navigating regulatory changes, including the Health Reform Legislation, which impacts pricing, benefits, and market operations.

Follow one dollar

Of each $1.00 of revenue in FY2012, UnitedHealth Group Inc kept $0.05.

  1. Revenue$110.62B100.0%
  2. Cost of revenue−$2.52B2.3%
  3. Gross profit$108.09B97.7%
  4. Operating costs−$98.84B89.4%
  5. Operating income$9.25B8.4%
  6. Interest, other & tax−$3.73B3.4%
  7. Net income$5.53B5.0%
Computed from 10-KFY2012filed February 7, 2013Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Where FY2012 revenue went

$110.62B
  • Other operating costs: $81.53B, 74% of revenue
  • SG&A: $17.31B, 16% of revenue
  • Net income: $5.53B, 5.0% of revenue
  • Cost of revenue: $2.52B, 2.3% of revenue
  • Interest, other & tax: $3.73B, 3.4% of revenue

Kept 5.0% as net income

Full revenue history →

Financial Statements

FY2012 against FY2011

Line itemFY2012FY2011Change
Revenue$110.62B$101.86B+8.6%
Cost of Revenue$2.52B$2.38B+5.8%
Gross Profit$108.09B$99.48B+8.7%
SG&A Expenses$17.31B$15.56B+11.2%
Operating Expenses$101.36B$93.40B+8.5%
Operating Income$9.25B$8.46B+9.3%
Interest Expense$632.00M$505.00M+25.1%
Net Income$5.53B$5.14B+7.5%
EPS (Basic)$5.38$4.81+11.9%
EPS (Diluted)$5.28$4.73+11.6%
Shares Outstanding (Basic)1.03B1.07B−4.0%
Shares Outstanding (Diluted)1.05B1.09B−3.8%

Frequently Asked Questions

  1. What were the main drivers of UnitedHealth Group's revenue growth in 2012?

    Revenue growth was primarily driven by an increase in the number of individuals served across its UnitedHealthcare businesses, particularly in the Medicare & Retirement and Community & State segments. Growth in Optum's health services and technology offerings also contributed significantly, along with premium rate increases reflecting underlying medical cost trends and the impact of the Amil acquisition in Brazil.

  2. How did the company manage medical costs and what was the medical care ratio?

    UnitedHealth Group managed medical costs through effective medical cost management strategies, including controlling unit costs and utilization trends. The consolidated medical care ratio for 2012 was 80.4%, a slight decrease from 80.8% in 2011, indicating effective cost control. Favorable medical reserve development also contributed positively to profitability.

  3. What is the significance of the Amil acquisition?

    The acquisition of Amil, a Brazilian health care company, was a major event in 2012, significantly expanding UnitedHealth Group's international presence and medical enrollment. It contributed substantially to revenue growth and diversified the company's geographic footprint.

  4. How is UnitedHealth Group returning capital to shareholders?

    The company actively returned capital through share repurchases and dividends. In 2012, UnitedHealth Group repurchased approximately 57 million shares for $3.1 billion and increased its quarterly cash dividend by 31% to an annual rate of $0.85 per share.